Kyung Nam Pharm Co Ltd
KOSDAQ:053950
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kyung Nam Pharm Co Ltd
KOSDAQ:053950
|
KR |
|
American Defense Systems Inc
OTC:ADFS
|
US |
|
Freedom Holding Corp
NASDAQ:FRHC
|
US |
|
8
|
88 Energy Ltd
OTC:EEENF
|
AU |
|
N
|
New York Times Co
XMUN:NYT
|
US |
|
Banco do Estado do Rio Grande do Sul SA
BOVESPA:BRSR6
|
BR |
|
D
|
Duke Energy Corp
SWB:D2MN
|
US |
|
Prada SpA
OTC:PRDSF
|
IT |
|
MANI Inc
TSE:7730
|
JP |
|
JSS Corp
TSE:6074
|
JP |
|
Ageas SA
MIL:1AGS
|
BE |
|
Evoke PLC
LSE:EVOK
|
GI |
|
T
|
TransDigm Group Inc
SWB:T7D
|
US |
|
A
|
Acsion Ltd
JSE:ACS
|
ZA |
|
Givaudan SA
SIX:GIVN
|
CH |
|
Public Storage
NYSE:PSA
|
US |
|
S
|
Shin-Etsu Chemical Co Ltd
XMUN:SEH
|
JP |
|
Kumba Iron Ore Ltd
OTC:KUMBF
|
ZA |
|
Paychex Inc
NASDAQ:PAYX
|
US |
|
Larsen & Toubro Ltd
NSE:LT
|
IN |
|
Tree Island Steel Ltd
TSX:TSL
|
CA |
|
B
|
Bayerische Motoren Werke AG
OTC:BAMXF
|
DE |
|
P
|
Pfizer Inc
DUS:PFE
|
US |
Bankruptcy Probability
Kyung Nam Pharm Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Kyung Nam Pharm Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
K
|
Kyung Nam Pharm Co Ltd
KOSDAQ:053950
|
42.8B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
650.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
362.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
354B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
218.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
193.9B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
288.8B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
157.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
128.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Kyung Nam Pharm Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Kyung Nam Pharm Co Ltd has total debt of 5.8B KRW. This includes both short-term (5.2B KRW) and long-term (685m KRW) debt.
You can find a full breakdown on its Balance Sheet.